Salarius Pharmaceuticals Inc
SLRX
Mkt cap
$4.92M
EV/Sales
N/A
P/E ratio
N/A
Revenue (qtr ended 2026-06-30)
$227,629
EPS (H1 2026)
$-8.64
Gross Margin (qtr ended 2026-06-30)
N/A
Profit Margin (qtr ended 2026-06-30)
-1042.84%
Beta
N/A
Div yield
N/A
Sector
Healthcare
Salarius Pharmaceuticals Inc (SLRX) is a biotechnology company listed on NASDAQ.
Latest reported SLRX revenue for 2026-06-30 was $227.6K. Net income was -$2.4M. SLRX currently screens at market cap $4.9M.
Use this SLRX research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full SLRX income, balance, and cash tables.
Salarius Pharmaceuticals Inc (SLRX) is a biotechnology company in the Healthcare sector.
Latest cached Salarius Pharmaceuticals Inc (SLRX) revenue for Jun 30, 2026 was $227.6K. Net income was -$2.4M. Statements: https://lician.com/financials/slrx
Salarius Pharmaceuticals Inc (SLRX) market capitalization is $4.9M on the latest cached snapshot.
The latest cached SLRX filing is 8-K · Jan 8, 2026. Filings: https://lician.com/sec/slrx